Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure

NCT02053246 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02053246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02053246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2014
Completion date
March 31, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure, heart failure with preserved ejection fraction, pulmonary hypertension